Search results
Insider Sale: EVP & Chief HR Officer Leann Smith Sells Shares of McKesson Corp (MCK)
GuruFocus.com via Yahoo Finance· 5 days agoOver the past year, Leann Smith has sold a total of 1,958 shares and has not purchased...of the...
Earnings call: Veeva Systems adjusts revenue guidance amid macro challenges
Investing.com· 4 days agoVeeva Systems Inc. (NYSE: NYSE: VEEV ), a cloud-computing company focused on pharmaceutical and life...
Coherus Biosciences retains Buy rating on strong launch progress By Investing.com
Investing.com· 5 days agoOn Thursday, Coherus Biosciences (NASDAQ:CHRS) maintained its Buy rating from TD (TSX:TD) Cowen,...
Insider Sale: Chief Development Officer William Guyer Sells 30,000 Shares of Corcept ... By...
Investing.com· 5 days agoOn May 28, 2024, William Guyer, the Chief Development Officer of Corcept Therapeutics Inc...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoClinical Microbiology Market Worth $6.9 billion | MarketsandMarkets™ PR Newswire CHICAGO, May 29, 2024 CHICAGO, May 29, 2024 /PRNewswire/ -- Clinical Microbiology Market in terms of revenue was estimated to be worth $5.0 billion in 2024 and is poised
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 6 days agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Believe And Two More Euronext Paris Growth Companies With High Insider Stakes
Simply Wall St. via Yahoo Finance· 1 day agoAmidst a backdrop of rising inflation and cautious monetary policy signals from the European Central...
Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape...
Digital Journal· 1 day agoAbout Nutriband Inc. We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent ...
The Secret Is Out: Here's the Dividend Stock That Warren Buffett Just Dumped $6.7 Billion Into
The Motley Fool via AOL· 5 days agoShould you follow Buffett's lead? Right now, the markets are experiencing some increased buying...